A Study to Evaluate the Effects of Aflibercept on QTc Interval in Cancer Patients

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2009
The primary objective of this study is to evaluate the effects of aflibercept on the QTc interval in cancer patients. Secondary objectives are to evaluate the effects of aflibercept on other electrocardiogram (ECG) parameters, clinical safety and pharmakokinetic (PK) parameters.
Epistemonikos ID: 9d56a5c16fbd76f53ddf89ae82a07515720cee05
First added on: May 05, 2024